Titan Pharmaceuticals, Inc. Stock or Unit Option Plan Expense
Titan Pharmaceuticals, Inc. reported Stock or Unit Option Plan Expense of $1.18 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2012-03-15
- Titan Pharmaceuticals, Inc. stock or unit option plan expense for fiscal 2011 was $1.18M, a 60.57% increase from fiscal 2010.
- Titan Pharmaceuticals, Inc. stock or unit option plan expense for fiscal 2010 was $733.00K, a 51.87% decline from fiscal 2009.
- Titan Pharmaceuticals, Inc. stock or unit option plan expense for fiscal 2009 was $1.52M.
| Period end | Stock or Unit Option Plan Expense 12 month |
|---|---|
| 2011-12-31 | $1.18M 10-K · filed 2012-03-15 |
| 2010-12-31 | $733.00K 10-K · filed 2012-03-15 |
| 2009-12-31 | $1.52M 10-K · filed 2012-03-15 |